drugset
drugset / Trial / NCT03822416

Treating Smokers With Mental Illness

NCT03822416 ↗

Phase 2 Completed 38 enrolled University of Minnesota Brown University · collabHennepin County Medical Center, Minneapolis · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a smoking cessation study that will enroll smokers who have been diagnosed with a severe mental illness. The study will use a combination of intensive tobacco treatment counseling and nicotine replacement therapy to assist smokers in cutting back on and quitting smoking over the course of six months.

Timeline

Start
2019-03-01
Primary completion
2020-05-04
Completion
2020-05-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg —
Subject Nicotine Unknown 4 mg —

Indications

bipolar I disorder bipolar II disorder major depressive disorder schizophrenia